Isarna Therapeutics

Isarna Therapeutics is focused on developing TGF-B inhibitors that stimulate the human immune system to fight cancer.

Isarna Therapeutics has an unmatched commitment to developing TGF-B inhibitors that stimulate the human immune system to effectively fight cancer. They are advancing a unique pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcomes.